Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susanne Wagner

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 12, 2020
Prognostic and predictive value of cell cycle progression (CCP) score in ductal carcinoma in situ of the breastMatteo Lazzeroni, Andrea DeCensi, Aliana Guerrieri-Gonzaga, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|September 5, 2018
Very small superparamagnetic iron oxide nanoparticles: Long-term fate and metabolic processing in atherosclerotic miceWolfram C Poller, Melanie Pieber, Philipp Boehm-Sturm, et al.
JCO Precision Oncology|September 14, 2020
Development and Validation of a Clinical Polygenic Risk Score to Predict Breast Cancer RiskElisha Hughes, Placede Tshiaba, Shannon Gallagher, et al.
European Journal of Cancer (Oxford, England : 1990)|August 4, 2015
Stratification of resectable lung adenocarcinoma by molecular and pathological risk estimatorsEmad Rakha, Maria J Pajares, Marius Ilie, et al.
JAMA Network Open|July 2, 2020
Association of a Polygenic Risk Score With Breast Cancer Among Women Carriers of High- and Moderate-Risk Breast Cancer GenesShannon Gallagher, Elisha Hughes, Susanne Wagner, et al.
JCO Precision Oncology|July 29, 2021
Comprehensive Breast Cancer Risk Assessment for <i>CHEK2</i> and <i>ATM</i> Pathogenic Variant Carriers Incorporating a Polygenic Risk Score and the Tyrer-Cuzick ModelShannon Gallagher, Elisha Hughes, Allison W Kurian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 20, 2013
Validation of a proliferation-based expression signature as prognostic marker in early stage lung adenocarcinomaIgnacio I Wistuba, Carmen Behrens, Francesca Lombardi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 15, 2014
Validation of a molecular and pathological model for five-year mortality risk in patients with early stage lung adenocarcinomaRaphael Bueno, Elisha Hughes, Susanne Wagner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 31, 2022
Clinical Validation of EndoPredict in Pre-Menopausal Women with ER-Positive, HER2-Negative Primary Breast CancerAnastasia Constantinidou, Yiola Marcou, Michael S Toss, et al.
Cancer|July 6, 2021
Performance of the IBIS/Tyrer-Cuzick model of breast cancer risk by race and ethnicity in the Women's Health InitiativeAllison W Kurian, Elisha Hughes, Timothy Simmons, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 12, 2020
Prognostic and predictive value of cell cycle progression (CCP) score in ductal carcinoma in situ of the breastMatteo Lazzeroni, Andrea DeCensi, Aliana Guerrieri-Gonzaga, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|September 5, 2018
Very small superparamagnetic iron oxide nanoparticles: Long-term fate and metabolic processing in atherosclerotic miceWolfram C Poller, Melanie Pieber, Philipp Boehm-Sturm, et al.
JCO Precision Oncology|September 14, 2020
Development and Validation of a Clinical Polygenic Risk Score to Predict Breast Cancer RiskElisha Hughes, Placede Tshiaba, Shannon Gallagher, et al.
European Journal of Cancer (Oxford, England : 1990)|August 4, 2015
Stratification of resectable lung adenocarcinoma by molecular and pathological risk estimatorsEmad Rakha, Maria J Pajares, Marius Ilie, et al.
JAMA Network Open|July 2, 2020
Association of a Polygenic Risk Score With Breast Cancer Among Women Carriers of High- and Moderate-Risk Breast Cancer GenesShannon Gallagher, Elisha Hughes, Susanne Wagner, et al.
JCO Precision Oncology|July 29, 2021
Comprehensive Breast Cancer Risk Assessment for <i>CHEK2</i> and <i>ATM</i> Pathogenic Variant Carriers Incorporating a Polygenic Risk Score and the Tyrer-Cuzick ModelShannon Gallagher, Elisha Hughes, Allison W Kurian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 20, 2013
Validation of a proliferation-based expression signature as prognostic marker in early stage lung adenocarcinomaIgnacio I Wistuba, Carmen Behrens, Francesca Lombardi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 15, 2014
Validation of a molecular and pathological model for five-year mortality risk in patients with early stage lung adenocarcinomaRaphael Bueno, Elisha Hughes, Susanne Wagner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 31, 2022
Clinical Validation of EndoPredict in Pre-Menopausal Women with ER-Positive, HER2-Negative Primary Breast CancerAnastasia Constantinidou, Yiola Marcou, Michael S Toss, et al.
Cancer|July 6, 2021
Performance of the IBIS/Tyrer-Cuzick model of breast cancer risk by race and ethnicity in the Women's Health InitiativeAllison W Kurian, Elisha Hughes, Timothy Simmons, et al.
Pageof 8